Suppr超能文献

初始单疗程后产前倍他米松抢救剂量的有效性

Effectiveness of a rescue dose of antenatal betamethasone after an initial single course.

作者信息

Vermillion S T, Bland M L, Soper D E

机构信息

Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston 29425, USA.

出版信息

Am J Obstet Gynecol. 2001 Nov;185(5):1086-9. doi: 10.1067/mob.2001.117633.

Abstract

OBJECTIVE

To evaluate the effects of a single rescue dose of antenatal betamethasone after an initial single course on the frequency of neonatal respiratory distress syndrome and perinatal infectious morbidity in pregnancies complicated with preterm labor and delivery.

STUDY DESIGN

We performed a cohort analysis of singleton pregnancies for which delivery occurred between 28 and 34 weeks' gestation after a single course of betamethasone administered before 28 weeks' gestation. Patients were then segregated into the following 2 groups on the basis of betamethasone exposure at the delivery admission: (1) a single 12-mg injection (rescue group) and (2) observation only (observation group). Patients who delivered infants within 24 hours of the rescue dose were excluded, as were those who had ruptured membranes for longer than 24 hours before delivery, those with diabetes that required insulin, and those with exposure to repeated doses of betamethasone before admission. Data were analyzed by use of the Student t test, chi2 test, and Fisher exact test. Multiple logistic regression was performed to examine the effect of each steroid dosing regimen on respiratory distress syndrome. Two-tailed P values <.05 were considered to be significant.

RESULTS

A total of 152 patients were included, with 89 in the rescue group and 63 in the observation group. Both groups were similar with respect to maternal demographics, mean gestational age at the initial single course and at delivery, mode of delivery, and mean birth weights. Rescue administration was significantly associated with a reduction in the frequency of respiratory distress syndrome (odds ratio, 0.44; 95% confidence interval, 0.2 to 0.9) and mean ventilator days (odds ratio, 0.44; 95% confidence interval, 0.2 to 0.8) compared with observation alone. All other studied perinatal outcomes analyzed were similar between the groups. Multiple logistic regression confirmed an independent association between a single rescue dose and a reduction in the frequency of respiratory distress syndrome (odds ratio, 0.40; 95% confidence interval, 0.2 to 0.9).

CONCLUSIONS

A single rescue dose of betamethasone is associated with a reduction in the frequency of respiratory distress syndrome without an apparent increase in perinatal infectious disease.

摘要

目的

评估妊娠合并早产及分娩时,在初次单疗程使用倍他米松后给予单次挽救剂量的倍他米松,对新生儿呼吸窘迫综合征发生率及围产期感染性疾病的影响。

研究设计

我们对单胎妊娠进行了队列分析,这些妊娠在妊娠28周前接受单次倍他米松疗程治疗后,于妊娠28至34周分娩。然后根据分娩入院时倍他米松的暴露情况将患者分为以下两组:(1)单次注射12毫克(挽救组)和(2)仅观察(观察组)。在挽救剂量后24小时内分娩的患者被排除,分娩前胎膜破裂超过24小时的患者、需要胰岛素治疗的糖尿病患者以及入院前接受多次倍他米松剂量的患者也被排除。数据采用Student t检验、卡方检验和Fisher精确检验进行分析。进行多因素逻辑回归以检验每种类固醇给药方案对呼吸窘迫综合征的影响。双侧P值<.05被认为具有统计学意义。

结果

共纳入152例患者,挽救组89例,观察组63例。两组在产妇人口统计学特征、初次单疗程及分娩时的平均孕周、分娩方式和平均出生体重方面相似。与仅观察相比,挽救给药与呼吸窘迫综合征发生率降低(优势比,0.44;95%置信区间,0.2至0.9)和平均呼吸机使用天数降低(优势比,0.44;95%置信区间,0.2至0.8)显著相关。分析的所有其他围产期结局在两组之间相似。多因素逻辑回归证实单次挽救剂量与呼吸窘迫综合征发生率降低之间存在独立关联(优势比,0.40;95%置信区间,0.2至0.9)。

结论

单次挽救剂量的倍他米松与呼吸窘迫综合征发生率降低相关,且围产期感染性疾病无明显增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验